| __timestamp | AbbVie Inc. | BioCryst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 15534000000 | 13486000 |
| Thursday, January 1, 2015 | 18359000000 | 46361000 |
| Friday, January 1, 2016 | 19805000000 | 23654000 |
| Sunday, January 1, 2017 | 21176000000 | 23484000 |
| Monday, January 1, 2018 | 25035000000 | 20182000 |
| Tuesday, January 1, 2019 | 25827000000 | 44734000 |
| Wednesday, January 1, 2020 | 30417000000 | 16136000 |
| Friday, January 1, 2021 | 38751000000 | 149906000 |
| Saturday, January 1, 2022 | 40640000000 | 264233000 |
| Sunday, January 1, 2023 | 33903000000 | 326751000 |
| Monday, January 1, 2024 | 0 |
Data in motion
In the competitive landscape of biopharmaceuticals, gross profit is a key indicator of a company's financial health and market position. Over the past decade, AbbVie Inc. has consistently outperformed BioCryst Pharmaceuticals, Inc. in terms of gross profit. From 2014 to 2023, AbbVie's gross profit surged by approximately 118%, peaking in 2022. In contrast, BioCryst's growth, while notable, was more modest, with a 2,320% increase over the same period, albeit from a much smaller base.
AbbVie's strategic investments and blockbuster drugs have propelled its financial success, while BioCryst's focus on niche markets has resulted in steady, albeit smaller, gains. This comparison highlights the diverse strategies within the biopharma sector and underscores the importance of scale and innovation in driving profitability.
Eli Lilly and Company vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Novo Nordisk A/S vs AbbVie Inc.
Gross Profit Analysis: Comparing AbbVie Inc. and Zoetis Inc.
AbbVie Inc. and GSK plc: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: AbbVie Inc. vs Teva Pharmaceutical Industries Limited
Gross Profit Comparison: AbbVie Inc. and Amneal Pharmaceuticals, Inc. Trends
Key Insights on Gross Profit: AbbVie Inc. vs Evotec SE
Merck & Co., Inc. and BioCryst Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Bio-Techne Corporation and BioCryst Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Perrigo Company plc and BioCryst Pharmaceuticals, Inc.
Veracyte, Inc. and BioCryst Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis